We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
34 hedge funds and large institutions have $15.9M invested in Rocket Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
450% more call options, than puts
Call options by funds: $33K | Put options by funds: $6K
6% more capital invested
Capital invested by funds: $15M → $15.9M (+$928K)
0.97% more ownership
Funds ownership: 7.3% → 8.26% (+0.97%)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
33% less funds holding
Funds holding: 51 → 34 (-17)
76% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 21
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
34
Holders Change
-17
Holders Change %
-33.33%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
9
Reduced
12
Closed
21
Calls
$33K
Puts
$6K
Net Calls
+$27K
Net Calls Change
-$828K
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.06M |
| 2 |
Jennison Associates
New York
|
+$1.78M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.18M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$726K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$345K |
Top Sellers
| 1 |
RCP
Rho Capital Partners
New York
|
-$4.99M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$451K |
| 3 |
CCI
Columbus Circle Investors
|
-$417K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$404K |
| 5 |
Goldman Sachs
New York
|
-$330K |
